SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-005145
Filing Date
2021-03-05
Accepted
2021-03-05 16:03:34
Documents
2
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 LATOUR rdgdoc.html 4  
1 FORM 4 LATOUR rdgdoc.xml 4 6455
2 latourpoa.htm EX-24 9459
  Complete submission text file 0001437749-21-005145.txt   17608
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 385 OYSTER POINT BLVD., SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address
Latour Wouter (Reporting) CIK: 0001652203 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 21718472